Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY – Get Free Report) shares saw unusually-strong trading volume on Thursday . Approximately 59,802 shares changed hands during mid-day trading, an increase of 382% from the previous session’s volume of 12,395 shares.The stock last traded at $10.97 and had previously closed at $11.12.
Santen Pharmaceutical Stock Performance
The company has a market cap of $3.67 billion and a P/E ratio of 0.10. The stock has a 50-day simple moving average of $10.96 and a 200 day simple moving average of $10.62.
About Santen Pharmaceutical
Santen Pharmaceutical Co, Ltd. is a Japan‐based specialty pharmaceutical company focused exclusively on ophthalmology. Headquartered in Osaka, Santen engages in the research, development, manufacture and marketing of prescription and over‐the‐counter products for the diagnosis and treatment of eye diseases. Its core product portfolio includes therapies for glaucoma, dry eye, retinal disorders, uveitis and post‐operative care, as well as surgical equipment and diagnostic agents designed to support comprehensive eye care.
With roots tracing back to the late 19th century, Santen has grown from a domestic manufacturer to a global ophthalmic specialist.
Further Reading
Receive News & Ratings for Santen Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santen Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
